TherapeuticsMD (TXMD) Interest & Investment Income (2014 - 2026)
TherapeuticsMD's (TXMD) quarterly Interest & Investment Income came in at $41000.0 in Q1 2026, up 41.38% YoY from $29000.0 in Q1 2025, and up 41.38% on a QoQ basis from $29000.0 in Q1 2025.
TherapeuticsMD (TXMD) Interest & Investment Income (2014 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 6 years of Interest & Investment Income data on file, last reported at $41000.0 in Q1 2026.
- Quarterly Interest & Investment Income rose 41.38% year-over-year to $41000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70000.0 (up 113.21% YoY) and the FY2025 annual result came in at $142000.0, up 5.19% from the prior year.
- Interest & Investment Income climbed to $41000.0 in Q1 2026, from $29000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $41000.0 in Q1 2026 to a low of $29000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69,000.00 |
| Mar 31, 2026 | 41,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Jun 30, 2017 | 3,832.00 |
| Mar 31, 2017 | 3,867.00 |
| Jun 30, 2016 | 2,863.00 |
| Mar 31, 2016 | 2,536.00 |
| Dec 31, 2015 | -6,111.00 |
| Sep 30, 2015 | 2,760.00 |
| Mar 31, 2015 | 18,513.00 |
| Dec 31, 2014 | 9,553.00 |
| Sep 30, 2014 | 9,364.00 |